A Triple Threat? The Role of Diet, Nutrition, and the Microbiota in T1D Pathogenesis
Open Access
- 1 April 2021
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 8
Abstract
In recent years the role of the intestinal microbiota in health and disease has come to the forefront of medical research. Alterations in the intestinal microbiota and several of its features have been linked to numerous diseases, including type 1 diabetes (T1D). To date, studies in animal models of T1D, as well as studies in human subjects, have linked several intestinal microbiota alterations with T1D pathogenesis. Features that are most often linked with T1D pathogenesis include decreased microbial diversity, the relative abundance of specific strains of individual microbes, and altered metabolite production. Alterations in these features as well as others have provided insight into T1D pathogenesis and shed light on the potential mechanism by which the microbiota plays a role in T1D pathogenesis, yet the underlying factors leading to these alterations remains unknown. One potential mechanism for alteration of the microbiota is through diet and nutrition. Previous studies have shown associations of diet with islet autoimmunity, but a direct contributing factor has yet to be identified. Diet, through introduction of antigens and alteration of the composition and function of the microbiota, may elicit the immune system to produce autoreactive responses that result in the destruction of the beta cells. Here, we review the evidence associating diet induced changes in the intestinal microbiota and their contribution to T1D pathogenesis. We further provide a roadmap for determining the effect of diet and other modifiable factors on the entire microbiota ecosystem, including its impact on both immune and beta cell function, as it relates to T1D. A greater understanding of the complex interactions between the intestinal microbiota and several interacting systems in the body (immune, intestinal integrity and function, metabolism, beta cell function, etc.) may provide scientifically rational approaches to prevent development of T1D and other childhood immune and allergic diseases and biomarkers to evaluate the efficacy of interventions.Keywords
Funding Information
- Juvenile Diabetes Research Foundation United States of America (3-SRA-2019-730-S-B)
- Children's Hospital Foundation
- National Institute of Diabetes and Digestive and Kidney Diseases
This publication has 137 references indexed in Scilit:
- Reversal of autoimmune diabetes by restoration of antigen-specific tolerance using genetically modified Lactococcus lactis in miceJournal of Clinical Investigation, 2012
- No association of vitamin D intake or 25-hydroxyvitamin D levels in childhood with risk of islet autoimmunity and type 1 diabetes: the Diabetes Autoimmunity Study in the Young (DAISY)Diabetologia, 2011
- Toward defining the autoimmune microbiome for type 1 diabetesThe ISME Journal, 2010
- Culture-independent identification of gut bacteria correlated with the onset of diabetes in a rat modelThe ISME Journal, 2009
- Differential NF-κB pathways induction by Lactobacillus plantarum in the duodenum of healthy humans correlating with immune toleranceProceedings of the National Academy of Sciences, 2009
- The Environmental Determinants of Diabetes in the Young (TEDDY) StudyAnnals of the New York Academy of Sciences, 2008
- Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetesJournal of Experimental Medicine, 2008
- Dietary Glycemic Index, Development of Islet Autoimmunity, and Subsequent Progression to Type 1 Diabetes in Young ChildrenThe Journal of Clinical Endocrinology & Metabolism, 2008
- Innate immunity and intestinal microbiota in the development of Type 1 diabetesNature, 2008
- Central Role of Defective Interleukin-2 Production in the Triggering of Islet Autoimmune DestructionImmunity, 2008